Venture Corporation Limited: Company Profile and SWOT Analysis

iCD Research
December 10, 2011
36 Pages - SKU: ICDR6718726
Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2014
12/10/2014 | published by: Global Markets Direct
Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2014’, provides an overview of the Vanda Pharmaceuticals Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Valens Therapeutics, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
Valens Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Valens Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Valens Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary Exploit Technologies Pte Ltd (Exploit Technologies) is a technology transfer company. It provides technologies for license in various sectors industries such as Electronics, energy, Environment, food, life sciences, medical devices, diagnostics, pharmaceuticals and others. The  |  read more...
USD 750
Vitatex Inc. - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary Vitatex Inc. (Vitatex) is a biotechnology company. The company research and develops new immunochemistry assays and reagents for the in-vitro diagnostic market. Its research products include Vita-Assays, Vita-Cap, tumor angiogenesis and metastasis monoclonal antibodies. Vitatex's  |  read more...
USD 750
Vodafone Group Enterprise 2014 Strategy Update
12/10/2014 | published by: IDC
Vodafone Group Enterprise 2014 Strategy Update This IDC Flash summarizes key findings from Vodafone Group Enterprise's analyst event held November 2014, in London, United Kingdom. This Flash summarizes the strategies and tactics that Vodafone's enterprise-focused teams  |  read more...
USD 1,500
Vaccibody AS - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
Vaccibody AS - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Vaccibody AS - Product Pipeline Review - 2014’, provides an overview of the Vaccibody AS’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Vietnam National Tobacco Corporation (VNTC)
11/8/2014 | published by: ERC Group
Global, Regional & National Tobacco Players, 2014: Vietnam National Tobacco Corporation (VNTC) Summary “Company Insight: Vietnam National Tobacco Corporation” is a new report by ERC that is the result of ERC's extensive market research covering Vietnam National  |  read more...
USD 975
Electronics For Imaging Inc (EFII: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/11/2014 | published by: Plunkett Research, Ltd.
Electronics For Imaging Inc (EFII: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Electronics For Imaging Inc, EFII: NAS) compared  |  read more...
USD 1,795
Hutchinson Technology (HTCH: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/11/2014 | published by: Plunkett Research, Ltd.
Hutchinson Technology (HTCH: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Hutchinson Technology, HTCH: NAS) compared to its top competitors  |  read more...
USD 1,795
Synaptics Inc (SYNA: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
11/11/2014 | published by: Plunkett Research, Ltd.
Synaptics Inc (SYNA: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Synaptics Inc, SYNA: NAS) compared to its top competitors  |  read more...
USD 1,795
 

SELECT A LICENSE

    Online Download  USD 99  
    Global Site License  USD 297  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!